Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Search by property

From Bioblast

This page provides a simple browsing interface for finding entities described by a property and a named value. Other available search interfaces include the page property search, and the ask query builder.

Search by property

A list of all pages that have property "Has abstract" with value "Mitochondria-shaping proteins modulate bioenergetics, apoptosis, Ca<sup>2+</sup> signalling and autophagy. The inner membrane pro-fusion and cristae shaping protein Optic atrophy 1 (Opa1) protects multiple tissues from damage by regulating cytochrome c release and mitochondrial respiratory efficiency, but whether this is mirrored by systemic changes in intermediary metabolism is unknown. Here we identify Opa1 as a key regulator of insulin sensitivity and adipose tissue function. Controlled Opa1 overexpression in the mouse reduces weight, improves glucose metabolism and insulin sensitivity, by reducing fat depots and favoring brownization of white adipose cells ''in vivo'' and ''in vitro''. Adipocyte-specific Opa1 deletion triggers a lipodystrophic phenotype with hyperglycemia, insulin resistance, brown adipose tissue whitening and hepatosteatosis. Our findings identify the genetic and metabolic basis for Opa1 role in a lean and insulin-sensitive phenotype, paving the way for novel therapeutic strategies to treat obesity and diabetes.". Since there have been only a few results, also nearby values are displayed.

Showing below up to 2 results starting with #1.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)


    

List of results

    • Bean 2016 Abstract Mito Xmas Meeting Innsbruck  + (Mitochondria-shaping proteins modulate bioMitochondria-shaping proteins modulate bioenergetics, apoptosis, Ca<sup>2+</sup> signalling and autophagy. The inner membrane pro-fusion and cristae shaping protein Optic atrophy 1 (Opa1) protects multiple tissues from damage by regulating cytochrome c release and mitochondrial respiratory efficiency, but whether this is mirrored by systemic changes in intermediary metabolism is unknown. Here we identify Opa1 as a key regulator of insulin sensitivity and adipose tissue function. Controlled Opa1 overexpression in the mouse reduces weight, improves glucose metabolism and insulin sensitivity, by reducing fat depots and favoring brownization of white adipose cells ''in vivo'' and ''in vitro''. Adipocyte-specific Opa1 deletion triggers a lipodystrophic phenotype with hyperglycemia, insulin resistance, brown adipose tissue whitening and hepatosteatosis. Our findings identify the genetic and metabolic basis for Opa1 role in a lean and insulin-sensitive phenotype, paving the way for novel therapeutic strategies to treat obesity and diabetes. therapeutic strategies to treat obesity and diabetes.)